Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis.
Kawahara
Chie
C
First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, 807-8555, Kitakyushu, Japan. tanaka@med.uoeh-u.ac.jp
Okada
Yosuke
Y
Tanikawa
Takahisa
T
Fukusima
Ayumi
A
Misawa
Haruo
H
Tanaka
Yoshiya
Y
D000368:Aged; D000369:Aged, 80 and over; D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced* / Q000628:therapy; D006955:Hypernatremia / Q000139:chemically induced* / Q000628:therapy; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*
D003879:Dermatologic Agents; D009824:Ointments; C055085:calcipotriene; D002117:Calcitriol